A father from Dumfries who lost his son to Meningitis has welcomed the news that all UK babies will soon have access to a vaccine against the B strain of the disease.
Michael Pattie's son David died in 1999 and he has campaigned since then for a vaccine to be available on the NHS.
The Government's agreement with drug company GlaxoSmithKline will mean the vaccine can be introduced later this year.
Previously the government had only agreed that children over two years old could get the vaccine.
Tim Backshall went to meet Lillie-Mai Jackson, who is learning to walk on prosthetic limbs, after both her legs and one of her arms were amputated.
Lillie-Mai Jackson's parents were told she had hours to live when she was diagnosed with meningitis at birth.
But now, she's taking her first steps.
You can find out more about meningitis at this links:
Three of Lillie Mai's limbs were amputated when she was just a baby. She's now learning to walk on prosthetic limbs.Read the full story ›
A Dumfries man who competed in The People's Strictly for Comic Relief has made a fresh call to speed up the introduction of a Meningitis B vaccine.
Michael Pattie lost his 13-year-old son David to another strain of the disease in 1999. However, he said the competition had given extra profile to a campaign to get the vaccine brought into use.
A man from Dumfries is calling on the government to speed up the introduction of a "life-saving" Meningitis vaccine.
Greg Hoare has this report:
Michael Pattie, from Dumfries, has described Bexsero as the 'Holy Grail' in treating the Meningitis B type of the disease.
He is calling for immediate use of the vaccine.
It was approved for use in the UK in March, but is still only available to private buyers.
The cause of the delay is ongoing negotiations over pricing between the drug company and the Department of Health.
The Department of Health has responded to claims that a price dispute is delaying the use of a new drug to fight Meningitis.
Dumfries man Michael Pattie has called for the urgent introduction of the vaccine, which was approved for use in the UK last March.
He has blamed disagreements over pricing as the cause of delays to the use of the vaccine.
The Department of health say that the current price published by Novartis Vaccine is too high.
“We are very clear that we want to see this vaccine introduced as soon as possible to help protect children from this devastating disease.”
“The JCVI recommended that a MenB vaccine be introduced, but only at a cost-effective price – below the price published by Novartis. We need to make sure NHS funds are used effectively and negotiations are continuing.”
The drug company behind Bexsero has responded to criticism from a man from Dumfries.
Michael Pattie says the availability of the 'holy grail' of treatment for Meningitis B as been delayed because of disputes about the prices between the company Novartis Vaccine and the Department of Health.
He has called for the introduction of the vaccine as soon as possible.
The company says it is working to come to an agreement.
"Novartis Vaccines is currently engaged in a procurement process with the UK Department of Health to agree a price for Bexsero to be included on the National Immunisation Programme.
"Whilst it is not possible to comment on the process, or predict how long it will last, both sides are working to come to an agreement and Novartis Vaccines stands ready to supply Bexsero immediately.
"Unfortunately the confidential nature of this process makes it impossible for Novartis Vaccines to comment further on any elements of the negotiations."
A man from Dumfries is calling for a new meningitis vaccine to be introduced as soon as possible. .
The vaccine, Bexsero, was approved for use in the UK last March, but is still only available to private buyers.
Michael Pattie claims that the delay is because of arguments between the drug company, Novartis Vaccines, and the Department of Health over the price of the drug.
Mr Pattie, whose 13-year-old son died of meningitis in 1999, is calling for an end to the current standstill.